Schizophrenia News
Related Searches

International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem’s Research Institute, Finds Genetic Asso
The July 1, 2009 advance online edition of the journal Nature includes three companion papers describing the results of genome-wide association studies (GWAS) of schizophrenia. Schizophrenia is an elusive and severe psychiatric disorder that affects up to 70 million people worldwide. The causes of schizophrenia remain largely unknown and there is no cure, though for some individuals the current treatments work well. There are multiple factors that increase the risk for schizophrenia, of which genetic factors are the most prominent, though not precisely identified yet. This highlights the need for a better understanding of the pathways leading to schizophrenia to enable development of better treatments.

How Can Astrology Help Your Health?
For the skeptics, there is medical research to prove certain illness are common in individuals born in particular months of the year An example is schizophrenia

An Educator's Guide To Student Mental Health
During the course of a school year, even a school day, teachers spend more time than anyone else with adolescents and teens And since the average age of onset for serious mental illnesses (including depression, panic and anxiety disorders, bipolar disorder, and schizophrenia) is seventeen, teachers are likely the first to recognize subtle changes in a young person developing a disease of the brain

CME Outfitters Announces neuroscienceCME Journal Club: "Adherence and Early Predictors of Response: Tools for Individualizing Treatment in Schizophren
CME Outfitters announces an upcoming neuroscienceCME activity titled "Adherence and Early Predictors of Response: Tools for Individualizing Treatment in Schizophrenia." Offered as an on-demand webcast accompanied by three live question and answer sessions, the activity will provide mental healthcare practitioners with the most recent data and clinical implications related to optimizing maintenance therapy in schizophrenia. The on-demand webcast and first live Q&A session will premiere on Monday, October 6, 2008.

Off-label Medicine Combinations are Predominant Treatment of Schizophrenics According to PLoS Article
In a new paper published in the online open-access journal PLoS ONE, http://dx.plos.org/10.1371/journal.pone.0003150, David Pickar and colleagues of Gabriel Sciences report that 74.5% of 200 community-based schizophrenic patients, who were individually interviewed and evaluated (including a review of clinical records), were treated with off-label medication treatments. Specifically, 42.5% of subjects reported that they were simultaneously treated with more than one antipsychotic drug, an unapproved treatment for schizophrenia.


Related Searches

Schizophrenia News


Privacy Policy | Copyright/Trademark Notification